Skip to main content
. 2020 Jun 23;8(2):335. doi: 10.3390/vaccines8020335

Figure 2.

Figure 2

Chemical structures of SARS-CoV and SARS-CoV-2 viral entry inhibitors: (A) emodin, (B) imatinib, (C) tetra-O-galloyl-beta-D-glucose (TGG), (D) luteolin, (E) N-(2-aminoethyl)-1-aziridineethanamine (NAAE), (F) chloroquine, (G) chlorpromazine, (H) E-64D, (I) 5705213, (J) camostat mesylate, and (K) nafamostat.